These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21782573)

  • 1. The therapeutic use of lipoic acid in diabetes: a current perspective.
    Coleman MD; Eason RC; Bailey CJ
    Environ Toxicol Pharmacol; 2001 Sep; 10(4):167-72. PubMed ID: 21782573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
    Ziegler D; Reljanovic M; Mehnert H; Gries FA
    Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
    Ziegler D
    Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of the antioxidant lipoic acid.
    Biewenga GP; Haenen GR; Bast A
    Gen Pharmacol; 1997 Sep; 29(3):315-31. PubMed ID: 9378235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fidarestat and alpha-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction.
    Yorek MA; Coppey LJ; Gellett JS; Davidson EP; Lund DD
    Exp Diabesity Res; 2004; 5(2):123-35. PubMed ID: 15203883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-lipoic Acid and diabetic neuropathy.
    Vallianou N; Evangelopoulos A; Koutalas P
    Rev Diabet Stud; 2009; 6(4):230-6. PubMed ID: 20043035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lipoic acid and dihydrolipoic acid on total erythrocytic thiols under conditions of restricted glucose in vitro.
    Coleman MD; Rimmer GS; Haenen GR
    Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):139-44. PubMed ID: 17244264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oxidised alpha-lipoic acid and alpha-tocopherol on xenobiotic-mediated methaemoglobin formation in diabetic and non-diabetic human erythrocytes in-vitro.
    Coleman MD; Walker CL
    Environ Toxicol Pharmacol; 2000 Jan; 8(2):127-132. PubMed ID: 10867372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular aspects of lipoic acid in the prevention of diabetes complications.
    Packer L; Kraemer K; Rimbach G
    Nutrition; 2001 Oct; 17(10):888-95. PubMed ID: 11684397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary evaluation of a novel method to monitor a triple antioxidant combination (vitamins E, C and α-lipoic acid) in diabetic volunteers using in vitro methaemoglobin formation.
    Coleman MD; Fernandes S; Khanderia L
    Environ Toxicol Pharmacol; 2003 Jun; 14(1-2):69-75. PubMed ID: 21782664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
    Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
    Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases.
    Gomes MB; Negrato CA
    Diabetol Metab Syndr; 2014; 6(1):80. PubMed ID: 25104975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.
    Yorek MS; Obrosov A; Shevalye H; Coppey LJ; Kardon RH; Yorek MA
    Neuropharmacology; 2017 Apr; 116():122-131. PubMed ID: 28025096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Alpha-Lipoic Acid in the Treatment of Diabetic Neuropathy: A Systematic Review.
    Abubaker SA; Alonazy AM; Abdulrahman A
    Cureus; 2022 Jun; 14(6):e25750. PubMed ID: 35812639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
    Davidson EP; Holmes A; Coppey LJ; Yorek MA
    Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid.
    Moini H; Packer L; Saris NE
    Toxicol Appl Pharmacol; 2002 Jul; 182(1):84-90. PubMed ID: 12127266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
    Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
    Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats.
    Keegan A; Cotter MA; Cameron NE
    Diabetologia; 1999 Mar; 42(3):343-50. PubMed ID: 10096788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.